Michael Scolaro

Michael Scolaro

Nov 29, 2017

Group 6 Copy 256
-3
References
  • 1. https://www.ncbi.nlm.nih.gov/pubmed/26558876
  • 2. https://www.ncbi.nlm.nih.gov/pubmed/26558876
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Dermatology AI Assistant to Empower Primary Care Providers in Zaatari Refugee Camp in Jordan

An AI-assisted dermatology tool for refugees, utilizing imaging and symptom questionnaires to improve diagnostic...

Understanding the perspective of women who use the Billings Ovulation Method

Fertility awareness-based methods (FABM) are a group of family planning methods that teach women how to...

Improving Collaborations for Neglected Tropical Diseases

Neglected tropical diseases (NTDs) infect over a billion of the poorest people in the world, yet only a...

Backer Badge Funded